View:
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported):
August 24, 2000
XEROX CORPORATION
(Exact name of registrant as specified in its charter)
New York 1-4471 16-0468020
(State or other (Commission File (IRS Employer
jurisdiction of Number) Identification
incorporation) No.)
800 Long Ridge Road
P. O. Box 1600
Stamford, Connecticut 06904-1600
(Address of principal executive offices)(Zip Code)
Registrant's telephone number, including area code:
(203) 968-3000
Item 5. Other Events
On August 24, 2000, an action was commenced in the United States District
Court for the District of Connecticut against Registrant and KPMG, LLP
("KPMG"), and Paul A. Allaire, G. Richard Thoman, Anne M. Mulcahy and Barry
D. Romeril ("Individual Defendants"). The action purports to be a class
action on behalf of the named plaintiff and all purchasers of Common Stock
of Registrant during the period from January 25, 2000 to July 27, 2000
("Class"). Among other things, the complaint alleges that each of
Registrant, KPMG and the Individual Defendants violated Sections 10(b) and
20(a) of the Securities Exchange Act of 1934, as amended, and Securities
and Exchange Commission Rule 10b-5 thereunder, by participating in a
fraudulent scheme that operated as a fraud and deceit on purchasers of
Registrant's Common Stock by disseminating materially false and misleading
statements and/or concealing material adverse facts relating to Registrant's
Mexican operations. The complaint alleges that this scheme deceived the
investing public regarding the true state of Registrant's financial
condition and caused the named plaintiff and other members of the alleged
Class to purchase Registrant's Common Stock at artificially inflated
prices. The complaint seeks unspecified compensatory damages in favor of
the named plaintiff and the other members of the alleged Class against
Registrant, KPMG and the Individual Defendants, jointly and severally,
including interest thereon, together with reasonable costs and expenses,
including counsel fees and expert fees.
Registrant and the Individual Defendants deny any wrongdoing alleged in
the complaint and intend to vigorously defend the action.
- -----------------------------------------------------------------------------
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
Registrant has duly authorized this report to be signed on its behalf by the
undersigned duly authorized.
XEROX CORPORATION
/s/ MARTIN S. WAGNER
--------------------------------
By: MARTIN S. WAGNER
Assistant Secretary
Dated: August 30, 2000